Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.cpcardiol.2021.100845 http://scihub22266oqcxt.onion/10.1016/j.cpcardiol.2021.100845 33994027!7972833!33994027     free     free     free       Curr+Probl+Cardiol 2021 ; 46 (10): 100845 Nephropedia Template TP {{tp|p=33994027|t=2021. Impact of Preinfection Left Ventricular Ejection Fraction on Outcomes in COVID-19 Infection |pdf=|usr=}}{{33994027}} gab.com Text Impact of Preinfection Left Ventricular Ejection Fraction on Outcomes in COVID-19 Infection JO: Curr Probl Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=33994027 #FOAvip Coronavirus disease 2019 (COVID-19) has high infectivity and causes extensive morbidity and mortality. Cardiovascular disease is a risk factor for adverse outcomes in COVID-19, but baseline left ventricular ejection fraction (LVEF) in particular has not been evaluated thoroughly in this context. We analyzed patients in our state's largest health system who were diagnosed with COVID-19 between March 20 and May 15, 2020. Inclusion required an available echocardiogram within 1 year prior to diagnosis. The primary outcome was all-cause mortality. LVEF was analyzed both as a continuous variable and using a cutoff of 40%. Among 396 patients (67 +/- 16 years, 191 [48%] male, 235 [59%] Black, 59 [15%] LVEF </=40%), 289 (73%) required hospital admission, and 116 (29%) died during 85 +/- 63 days of follow-up. Echocardiograms, performed a median of 57 (IQR 11-122) days prior to COVID-19 diagnosis, showed a similar distribution of LVEF between survivors and decedents (P = 0.84). Receiver operator characteristic analysis revealed no predictive ability of LVEF for mortality, and there was no difference in survival among those with LVEF </=40% versus >40% (P = 0.49). Multivariable analysis did not change these relationships. Similarly, there was no difference in LVEF based on whether the patient required hospital admission (56 +/- 13 vs 55 +/- 13, P = 0.38), and patients with a depressed LVEF did not require admission more frequently than their preserved-LVEF peers (P = 0.87). A premorbid history of dyspnea consistent with symptomatic heart failure was not associated with mortality (P = 0.74). Among patients diagnosed with COVID-19, pre-COVID-19 LVEF was not a risk factor for death or hospitalization. Twit Text FOAVip Impact of Preinfection Left Ventricular Ejection Fraction on Outcomes in COVID-19 Infection ????Curr Probl Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=33994027 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33994027 #FOAvip English Wikipedia <ref>{{Cite pmid|33994027}}</ref> Impact of Preinfection Left Ventricular Ejection Fraction on Outcomes in COVID-19 Infection #MMPMID33994027 Morin DP; Manzo MA; Pantlin PG; Verma R; Bober RM; Krim SR; Lavie CJ; Qamruddin S; Shah S; Tafur Soto JD; Ventura H; Price-Haywood EG Curr Probl Cardiol 2021[Oct]; 46 (10): 100845 PMID33994027show ga Coronavirus disease 2019 (COVID-19) has high infectivity and causes extensive morbidity and mortality. Cardiovascular disease is a risk factor for adverse outcomes in COVID-19, but baseline left ventricular ejection fraction (LVEF) in particular has not been evaluated thoroughly in this context. We analyzed patients in our state's largest health system who were diagnosed with COVID-19 between March 20 and May 15, 2020. Inclusion required an available echocardiogram within 1 year prior to diagnosis. The primary outcome was all-cause mortality. LVEF was analyzed both as a continuous variable and using a cutoff of 40%. Among 396 patients (67 +/- 16 years, 191 [48%] male, 235 [59%] Black, 59 [15%] LVEF 40% (P = 0.49). Multivariable analysis did not change these relationships. Similarly, there was no difference in LVEF based on whether the patient required hospital admission (56 +/- 13 vs 55 +/- 13, P = 0.38), and patients with a depressed LVEF did not require admission more frequently than their preserved-LVEF peers (P = 0.87). A premorbid history of dyspnea consistent with symptomatic heart failure was not associated with mortality (P = 0.74). Among patients diagnosed with COVID-19, pre-COVID-19 LVEF was not a risk factor for death or hospitalization. |*COVID-19[MESH] |*Heart Failure[MESH] |COVID-19 Testing[MESH] |Humans[MESH] |Male[MESH] |SARS-CoV-2[MESH] |Stroke Volume[MESH]Impact of Preinfection Left Ventricular Ejection Fraction on Outcomes (epmc).pdf DeepDyve Pubget Overpricing